FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
02/04/2026
Voltar para busca
Dado oficial do USPTO
VIVIBEN
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: Estados Unidos
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
35
Atualização mais recente
03/04/2026
Tipo de marca
Mista
Classes Nice
1, 5, 29, 30
Data de depósito
08/02/2022
Data de registro
02/09/2025
Data de expiração
-
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
02/09/2025
Última transação
03/04/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
3
Tipo de titular
16
Localização do titular
IT
Examinador
COUGHLAN, REBECCA D.
Unidade examinadora
M40
Localização atual
GENERIC WEB UPDATE
Descrição da marca
The trademark consists of an imprint depicting the wording "VIVIBEN" in fancy characters, preceded by a stylized twig bearing three stylized leaves and flanked with three stylized oval figures.
Titulares e representantes
Titulares
FRAU PHARMA S.R.L.
Representantes
Keith A. Weltsch Scully, Scott, Murphy & Presser, P.C.
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 29Classe 30
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Chemical additives for use in the manufacture of food products; vitamins for use in the manufacture of food products; chemical additives for use in the manufacture of food as enrichment of food composition; vitamins for use in the manufacture of food as enrichment of food composition; chemical productschemical additives to be used in the manufacture of food supplements; chemical productschemical additives to be used in the manufacture of pharmaceuticals and veterinary products; vitamins to be used in the manufacture of pharmaceutical and veterinary products; oleoylethanolamide to be used in the production of food and reinforced food; oleoylethanolamide to be used in the production of pharmaceutical and veterinary products; oleoylethanolamide to be used in the production of medical food; oleoylethanolamide to be used in the production of dietary ingredients in the nature of dietary supplements and food supplements; oleoylethanolamide and palmitoylethanolamide combination for use in the production of pharmaceutical and veterinary products; oleoylethanolamide and palmitoylethanolamide combination for use in the production of food and medical food; oleoylethanolamide and palmitoylethanolamide combination for use in the production of food supplements; oleoylethanolamide and palmitoylethanolamide combination used in the manufacture of dietary ingredients in the nature of dietary supplements; anandamide for use in the production of medical food; anandamide for use in the production of food supplements; anandamide for use in the production of pharmaceutical products; combination of oleoylethanolamidepalmitoylethanolamideanandamide for use in the production of foodmedical foodfood supplementsdietary ingredientspharmaceutical and veterinary products; anandamide with purity from 10 percent to 99 percent for use in the production of foodmedical foodfood supplementsdietary ingredientspharmaceutical and veterinary products; oleoylethanolamide with purity from 10 percent to 99 percent for use in the production of foodmedical foodfood supplementsdietary ingredientspharmaceutical and veterinary products; spermidinesperminealiphatic polyamine used in the production of food and medical food; spermidinesperminealiphatic polyamine to be used in the production of pharmaceutical and veterinary products; spermidinesperminealiphatic polyamine used in the production of food supplements and dietary ingredients; spermidinesperminealiphatic polyamine used in the manufacture of food to reinforce or enrich foodfood extract and fermented food; polyamines and acyl ethalonammides combination for use in the production of foodfood supplementspharmaceuticalsdietary products in the nature of dietary supplements; phosphatidylserinephosphatidylcholinephosphatidylethanolaminephosphatidylenositol as single entity to be used in the manufacture of foodmedical foodfood supplementspharmaceuticalveterinary products; natural phospholipids (PSPCPEPI) and acyl ethanolammides combination in powder form and in oil dispersion or emulsion for use in the manufacture of medical foodfood supplements; combination of natural phospholipids (PSPCPEPI)spermidinespermine in powder form and in oil dispersion or emulsion for use in the manufacture of medical foodfood supplements; combination of natural phospholipids (PSPCPEPI)L (-) methyl tetraidofolic acid or its salts in powder and fluid form for use in the manufacture of medical foodfood supplements; natural lecithynes added with spermidinespermine and other natural aliphnatic polyamines in powder and oil form for use in the manufacture of medical foodfood supplements; natural lecithynes added with L (-) methyl tetraidofolic acid and or folic acid in powder and oil form for use in the manufacture of medical foodfood supplements; any hemp in the goods being solely derived from hemp with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis; none of the foregoing goods containing CBD
Classe 5
Nutraceuticals for use in therapeutical dietsfor the treatment of inflammationcardiological conditionsdiabetesobesity or overweight people; nutraceuticals for use as dietary supplements; vitamin preparations; dietetic foodsbakery goods adapted for medical purposes; wheat germ dietary supplements; dietary supplements for animals; food supplements containing folic acidmethyltetrahydrofolic acidL (-) methyl tetraidofolic acid and its salts; nutraceutical preparations for medical purposesto be used to improve the quality of life of oncological patientsfor the treatment of cancer; pharmaceutical products for use by human beingsocular pharmaceuticals; veterinary productsdietary supplement nutraceuticalsamino acids and biological preparations for veterinary purposes for the treatment of cancer; dietetic foods adapted for medical use; dietary supplements for human beings and animals; dietary food supplements for medical use containing oleoylethanolamidepalmithoylethanolamideanandamidespermidinesperminephosphatidylserinenatural phospholipidsL (-) methyltetrahydrofolic acid and its saltsadded or enriched with the above chemical nutrients to improve the nutritional value or the health benefitseventually added with other products excipientsprocessing aids used in human or animal diet; any hemp in the goods being solely derived from hemp with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis; none of the foregoing goods containing CBD
Classe 29
Animal fats for food; blended oil for food; soya milk; yogurt; breakfast yogurt; milk; cheese; fermented milk; goat milk; powdered milk; processed shell fruits; condensed milk; food products made from meatfishpoultry and gamemeat-based snack foodsfish-based snack foods; food products made from fruits and vegetablesdried fruits and vegetablespreserved fruits and vegetablescooked fruits and vegetables; all of the foregoing goods featuring palmithoylethanolamideoleoylethanolamideanandamidepoliaminesspermidinesperminephosphatidylserinebeing addedalone and natural phospholipid in combination with the aforementioned goods; any hemp in the goods being solely derived from hemp with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis; none of the foregoing goods containing CBD
Classe 30
Chocolate; ice cream; biscuits; breakfast cereals; pizzas; bakery goods; rice; popcorn; soya flour; starch-based thickeners for whipped cream; flour; bread; pastries; frozen confectionery; fruit jellies being candies; baking powder; cooking salt; food products made from riceflour and cerealsriceflour and processed cereals with added folic acidmethyltetrahydrofolic acidL (-) methyltetrahydrofolic acid and its saltsfolic acid derivates; food products being pastrypetit fours and confectionery made of sugar; all of the foregoing goods featuring palmithoylethanolamideoleoylethanolamideanandamidepoliaminesspermidine and spermine phosphatidylserinebeing addedalonenatural phospholipid in combination with the aforementioned goods; any hemp in the goods being solely derived from hemp with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis; none of the foregoing goods containing CB
Publicações
Histórico de despachos e eventos da marca no USPTO.
35 publicações encontradas
FICS
FINAL DISPOSITION NOTICE SENT TO IB
16/03/2026
FIMP
FINAL DISPOSITION PROCESSED
16/03/2026
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
02/12/2025
CHPN
POST PUBLICATION AMENDMENT – NOT ENTERED
07/10/2025
APET
ASSIGNED TO PETITION STAFF
06/10/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
02/09/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
02/09/2025
EPPA
TEAS POST PUBLICATION AMENDMENT RECEIVED
26/08/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
15/07/2025
PUBO
PUBLISHED FOR OPPOSITION
15/07/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/07/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/06/2025
XAEC
EXAMINER'S AMENDMENT ENTERED
12/06/2025
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
12/06/2025
GNEA
EXAMINERS AMENDMENT E-MAILED
12/06/2025
CNEA
EXAMINERS AMENDMENT -WRITTEN
12/06/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/06/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/06/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/06/2025
RFNT
REFUSAL PROCESSED BY IB
21/12/2024
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
03/12/2024
RFRR
REFUSAL PROCESSED BY MPU
03/12/2024
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
26/02/2024
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
07/02/2024
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
07/02/2024
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
14/08/2023
CNRT
NON-FINAL ACTION WRITTEN
14/08/2023
DOCK
ASSIGNED TO EXAMINER
17/01/2023
DOCK
ASSIGNED TO EXAMINER
08/12/2022
DOCK
ASSIGNED TO EXAMINER
21/11/2022
MAFR
APPLICATION FILING RECEIPT MAILED
13/09/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/09/2022
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
06/09/2022
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
01/09/2022
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace VIVIBEN ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.